tvty-8k_20180524.htm

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8‑K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of report (Date of earliest event reported):  May 25, 2018 (May 24, 2018)

 

TIVITY HEALTH, INC.

 

(Exact name of registrant as specified in its charter)

 

Delaware

 

000-19364

 

62-1117144

(State or other jurisdiction
of incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

701 Cool Springs Boulevard

Franklin, Tennessee

 

 

37067

(Address of principal executive offices)

 

(Zip Code)

 

(615) 614-4929

(Registrant's telephone number, including area code)

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  


Item 5.07. Submission of Matters to a Vote of Security Holders.

 

(a)

The Annual Meeting of Stockholders (“Annual Meeting”) of Tivity Health, Inc. (the “Company”) was held on May 24, 2018, at which a total of 36,612,633 shares of the Company's common stock, out of a total of 39,847,047 shares of the Company's common stock outstanding and entitled to vote, were present in person or represented by proxies.

 

(b)

The following proposals were voted upon at the Annual Meeting:

 

(i)

To elect Sara J. Finley, Archelle Georgiou, M.D., Robert J. Greczyn, Jr., Peter A. Hudson, M.D., Beth M. Jacob, Bradley S. Karro, Paul H. Keckley, Ph.D., Lee A. Shapiro, Donato J. Tramuto and Kevin G. Wills as directors of the Company. The results of the election of the above-mentioned nominees were as follows:

 

 

 

For

 

Against

 

Abstain from
Voting

 

Broker
Non-Votes

Sara J. Finley

 

34,876,609

 

28,864

 

75,451

 

1,631,709

Archelle Georgiou, M.D.

 

34,804,983

 

100,450

 

75,491

 

1,631,709

Robert J. Greczyn, Jr.

 

34,803,332

 

101,761

 

75,831

 

1,631,709

Peter A. Hudson, M.D.

 

34,842,389

 

61,203

 

77,332

 

1,631,709

Beth M. Jacob

 

34,876,613

 

28,861

 

75,450

 

1,631,709

Bradley S. Karro

 

34,845,900

 

59,192

 

75,832

 

1,631,709

Paul H. Keckley, Ph.D.

 

34,802,213

 

101,480

 

77,231

 

1,631,709

Lee A. Shapiro

 

34,846,965

 

58,027

 

75,932

 

1,631,709

Donato J. Tramuto

 

34,847,825

 

65,005

 

68,094

 

1,631,709

Kevin G. Wills

 

34,837,992

 

67,000

 

75,932

 

1,631,709

 

 

(ii)

To consider and act upon a non-binding, advisory vote to approve compensation of the Company's named executive officers. The voting results were as follows:

 

For

 

Against

 

Abstain from
Voting

 

Broker
Non-Votes

34,380,480

 

486,086

 

114,358

 

1,631,709

 

 

(iii)

To ratify the appointment of PricewaterhouseCoopers LLP as the Company's independent registered public accounting firm for fiscal 2018. The voting results were as follows:

 

For

 

Against

 

Abstain from
Voting

 

Broker
Non-Votes

36,528,046

 

11,135

 

73,452

 

N/A

 

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

TIVITY HEALTH, INC.

 

 

 

By: 

 

/s/ Adam Holland

 

 

 

Name: Adam Holland

 

 

 

Title: Chief Financial Officer

 

Date: May 25, 2018